William Ashton

Insider Reports History

Entity
Individual
Location
C/O Harrison Consulting Group, Po Box 283, Newtown Square, PA
Signature
/s/ Ryan D. Lake, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William Ashton:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Baudax Bio, Inc. Director Common Stock 42.5K $108K $2.55 Jun 15, 2022 Direct
Societal CDMO, Inc. Director Common Stock 0 $0 $1.10 Apr 8, 2024 Direct
Societal CDMO, Inc. Director Stock Option (Right to Buy) 0 Apr 8, 2024 Direct
SPECTRUM PHARMACEUTICALS INC Director Common Stock, $0.001 par value 0 $1.10 Jul 31, 2023 Direct
SPECTRUM PHARMACEUTICALS INC Director Stock Option (Right to Buy) 0 Jul 31, 2023 Direct

Insider Reports Filed by William Ashton

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SCTL Societal CDMO, Inc. Apr 8, 2024 4 -$290K 4 Apr 8, 2024 Director
SCTL Societal CDMO, Inc. Aug 28, 2023 1 $10.1K 4 Aug 28, 2023 Director
SPPI SPECTRUM PHARMACEUTICALS INC Jul 31, 2023 2 $0 4 Aug 1, 2023 Director
SCTL Societal CDMO, Inc. May 17, 2023 2 $0 4 May 19, 2023 Director
SPPI SPECTRUM PHARMACEUTICALS INC Aug 31, 2022 2 $0 4 Sep 2, 2022 Director
SPPI SPECTRUM PHARMACEUTICALS INC Jun 21, 2022 1 -$3.36K 4 Jun 22, 2022 Director
BXRX Baudax Bio, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
SCTL Societal CDMO, Inc. May 18, 2022 2 $0 4 May 20, 2022 Director
SPPI SPECTRUM PHARMACEUTICALS INC Jun 17, 2021 3 -$38.2K 4 Jun 22, 2021 Director
SCTL Recro Pharma, Inc. Apr 20, 2021 1 $0 4/A May 17, 2021 Director